Hormonal

Gonadorelin

Also known as: GnRH, LHRH, Factrel

FDA Approved
Share:

Popular For

Hormone stimulation, fertility, TRT support

Key Facts: Gonadorelin

Category
Hormonal
FDA Status
FDA Approved
Clinical Status
FDA Approved - Diagnostic and therapeutic uses
Administration
IV, subcutaneous, or pulsatile pump
Typical Dose
100-500 mcg 2-3x weekly
Frequency
2-3x weekly
Evidence Level
FDA Approved
Duration
Single dose (diagnostic) or ongoing (therapeutic)
Also Known As
GnRH, LHRH, Factrel

Mechanism of Action

Gonadorelin stimulates the pituitary to release LH and FSH. Pulsatile administration supports natural hormone production, while continuous administration causes desensitization and hormone suppression. Effects depend entirely on dosing pattern.

Research Summary

FDA approved for diagnostic testing of pituitary function. Used to stimulate testosterone production when given in pulses. Continuous use leads to chemical castration effect used in prostate cancer and endometriosis.

Clinical Status:FDA Approved - Diagnostic and therapeutic uses
Trial Progress:FDA Approved
Pre
I
II
III
IV
FDA

Dosing Information

FDA Approved·Human clinical trials completed, FDA approved

Typical Dosing

Community experience

Common Dose

100-500 mcg 2-3x weekly

Range

50-500 mcg per dose

Frequency

2-3x weekly

GnRH analog for maintaining testosterone during TRT. Often dosed with HCG protocols.

Research Dosing

Scientific studies

Varies by indication

Doses from Studies

100 mcg IV/SC for diagnostic testing

FDA Approved Labeling - Prescribed dose

Pulsatile: varies by protocol

FDA Approved Labeling - Prescribed dose

Duration

Single dose (diagnostic) or ongoing (therapeutic)

Administration

IV, subcutaneous, or pulsatile pump

Timing & Administration

Best Time to Take

Morning or as clinically directed

As prescribed, often pulsatile

Food Recommendation

With or without food

Why This Timing?

GnRH analog used for hormone stimulation. Timing depends on specific clinical protocol.

Possible Side Effects

Not everyone experiences these effects. Individual responses vary based on dosage, duration, and personal factors.

  • Injection site reactions
  • Headache
  • Flushing
  • Nausea
  • Risk of multiple births
  • May worsen hormone-dependent cancers
  • Long-term: bone density decrease

References

Related Peptides

Peptides commonly compared with Gonadorelin or used in similar applications.

Looking for a trusted vendor?

Pro members get access to verified vendors with quality standards & exclusive discount codes.

View Verified Vendors
PRO

Want updates on Gonadorelin research?

Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.